Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

Clinical trial NCT01239745 · TERMINATED

Trial details

NCT number: NCT01239745
Sponsor: Pfizer
Status: TERMINATED
Study type: OBSERVATIONAL

Breast Neoplasms

Start date: 2011-04-01
Primary completion: 2011-10-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.